Schindler R A, Kessler D K
Am J Otol. 1987 May;8(3):247-55.
Clinical trials of the UCSF/Storz multichannel cochlear implant were initiated in February 1985, under the sponsorship of Storz Instrument Company. This four-channel device uses simultaneous bipolar, radial stimulation and a vocoder-based speech processing scheme. To date, eighteen patients have been implanted with the UCSF/Storz implant at four clinical centers in the United States. Based on data accumulated through June 1986, fifteen of these patients had received their speech processors and were given at least an initial evaluation of their performance with the implant. Results have been very encouraging, with all but two of these patients obtaining some degree of open-set auditory-only speech recognition. Most patients have demonstrated improvement over time without extensive rehabilitative intervention and all patients have attained an enhancement in lip-reading ability, as measured with a tracking procedure. According to a self-rated performance scale, all patients have experienced improvement in general communicative function since receiving the implant.
1985年2月，在斯托兹仪器公司的赞助下，开展了加州大学旧金山分校/斯托兹多通道人工耳蜗的临床试验。这种四通道装置采用同步双极、径向刺激和基于声码器的语音处理方案。到目前为止，在美国的四个临床中心，已有18名患者植入了加州大学旧金山分校/斯托兹人工耳蜗。根据截至1986年6月积累的数据，其中15名患者已收到他们的语音处理器，并至少对他们使用该植入物的性能进行了初步评估。结果非常令人鼓舞，除两名患者外，所有这些患者都获得了一定程度的仅通过听觉的开放式语音识别能力。随着时间的推移，大多数患者在没有广泛康复干预的情况下都表现出了改善，并且所有患者在通过跟踪程序测量时，唇读能力都有所提高。根据自我评定的性能量表，所有患者自接受植入物以来，在一般沟通功能方面都有改善。
